Skip to main content
. 2022 Jul 19;2022:1201977. doi: 10.1155/2022/1201977

Table 1.

Characteristics of studies.

Study Phase Trial design Key inclusion criteria T2DM Duration (weeks) Sample size lira/placebo Mean BMI (SD) lira/placebo at baseline Diet/behavioural therapy
Astrup et al. [24] 2 Double-blind 18–65 years, with BMI of 30–40 kg/m², and FPG of less than 7 mmol/L at the run-in period No 20 93 98 34·8 (2·8) 34.9 (2.8) Reduced-calorie diet and maintain or increase physical activity
Blackman et al. [25] 3 Double-blind 18–64 years with BMI ≥30 kg m2 diagnosed with moderate/severe OSA No 32 180 179 38.9 (6.4) 39.4 (7.4) Reduced-calorie diet and increased physical activity
Davies et al. [26] 3 Double-blind Age 18 years or older with BMI of ≥27.0 taking 0 to 3 oral hypoglycaemic agents and HbA1c level 7.0% to 10.0% Yes 56 423 212 37.1 (6.5) 37.4 (7.1) Reduced-calorie diet and increased physical activity
Garvey et al. [27] 3 Double-blind Aged ≥18 years and BMI ≥27 kgm2 with an ≥HbA1c 6.0 to ≥10% and T2DM treated with basal insulin and less than or equal to two OADs Yes 56 198 198 35.9 (6.5) 35.3 (5.8) Intensive behaviour therapy
Gudbergsen et al. [28] 4 Double-blind Aged 18 and 74 y with BMI ≥27 kg m2 with knee osteoarthritis No 52 80 76 32.8 (5.5) 31.3 (4.0) Nutritional counselling
Halawi et al. [29] 2 Double-blind Aged 18 and 65 years with BMI ≥27.0 kg/m2, with an obesity-related comorbidity, and adults with obesity (BMI >30 kg/m²), No 26 19 21 37.2 (7.5) 34.6 (2.6) Dietary and exercise interventions
Lean et al. [30] 2 Double-blind Aged 18–65 yrs with BMI ≥30 and ≤40 kgm and FPG <7.0 mmolL No 52 93 98 34.8 (2.8) 34.9 (2.8) Reduced-calorie diet and increased physical activity
Nexøe-Larsen et al. [31] 1 Double-blind Aged 18 and 64 years with BMI ≥27.0 kg/m2, ultrasound assessment of gallbladder volume of acceptable quality at screening overweight and obese subjects No 12 26 26 32.5 (3.6) 32.6 (3.3) Nutritional and physical activity counselling
O'Neil et al. [32] 2 Double-blind Aged ≥18 years and BMI ≥30 kgm−2 No 52 103 136 38·6 (6·6) 40·1 (7·2) Dietary and exercise interventions
Pi-Sunyer et al. [33] 3 Double-blind Aged ≥18 years and BMI ≥30 kgm−2 or ≥27 kgm2 with comorbidities of treated or untreated dyslipidaemia and/or treated or untreated hypertension No 56 2487 1244 38.3 (6.4) 38.3 (6.3) Reduced-calorie diet and increased physical activity
Tronieri et al. [34] 4 Open label Aged 21–70 years with BMI ≥30 and ≤55 kg/m² and had no serious medical or psychological conditions No 52 36 37 39.2 (5.0) 37.6 (4.1) Intensive behaviour therapy
Wadden et al. [35] 3 Double-blind Aged ≥18 years with BMI ≥30 kgm2 or ≥27 kgm2 with comorbidities of treated or untreated dyslipidaemia and/or treated or untreated hypertension No 56 212 210 38.3 (6.4) 38.3 (6.3) Reduced-calorie diet and increased physical activity
Wadden et al. [36] 4 Open label Aged 21–70 years with BMI of 30–55 kg/m2; prior lifetime weight-loss effort with diet and exercise No 52 50 50 38.5 (5.4) 38.0 (4.3) Intensive behaviour therapy
Wadden et al. [37] 3 Double-blind Aged ≥18 years, with BMI ≥30 kg/m2 No 56 142 140 39.3 (6.8) 38.7 (7.2) Intensive behaviour therapy